Precigen
PGEN
Precigen (PGEN) news
Recent news
Precigen's Adenoverse gets FDA platform technology designation
Precigen Inc. has received the FDA’s platform technology designation for its Adenoverse platform, a development that could streamline the regulatory pathway for future gene therapy products built on this technology. The platform technology designation is part of the FDA’s initiative to encourage…
AInvest Wire · Sep 21, 2026Precigen, Inc.: H.C. Wainwright raises target price to $18 from $14
AInvest Wire · Aug 5, 2026Precigen Q2 revenue USD 54.978 million
AInvest Wire · Aug 4, 2026Precigen Q2 EPS USD 0.05
AInvest Wire · Aug 4, 2026Precigen 2Q revenue $55.0M, estimate $27.8M
AInvest Wire · Aug 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.